Gsa And Benelux Point Care Testing Poct Market
市场规模（十亿美元）
CAGR :
% 
USD
3.63 Billion
USD
9.07 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 3.63 Billion |
 Market Size (Forecast Year) |
USD 9.07 Billion |
 CAGR |
% |
| Major Markets Players |
|
GSA 和 Benelux 即時診斷 (POCT) 市場，按產品類型（血糖監測產品、傳染病檢測產品、心臟代謝監測產品、懷孕和生育檢測產品、血液學檢測產品、凝血監測產品、藥物濫用 (DOA)檢測產品、尿液分析檢測產品、膽固醇檢測產品、腫瘤/癌症標記檢測產品、糞便隱匿檢測產品等）、按平台（橫向流動分析/免疫層析測試、免疫測定、試紙、分子診斷、臨床化學測定、微流體、血液學等）、按應用（血糖、傳染病、生命體徵監測、心臟監測、凝血、血液學、非侵入性 SpO2 監測監測、全血分析等）、依處方模式（處方檢測和非處方檢測）、終端使用者（醫院、家庭護理、診所、實驗室、診斷中心、病理實驗室、門診手術中心、老年護理中心等）、分銷管道（直接投標、零售、線上銷售等）—產業趨勢及預測（至 2032 年）
即時檢驗（POCT）市場規模
- 2024 年， GSA 即時診斷檢測 (POCT) 市場規模價值為36.3 億美元，預計到 2032 年將達到 90.7 億美元，預測期內 複合年增長率為 12.1%。
- 2024 年，比荷盧三國即時診斷檢測 (POCT) 市場規模價值8.82 億美元，預計到 2032 年將達到 18.19 億美元，預測期內 複合年增長率為 9.5%。
- 這一增長受到多種因素的推動，例如對快速診斷結果的需求不斷增長、慢性病和傳染病的患病率不斷上升以及便攜式診斷技術的進步
即時檢驗（POCT）市場分析
- 即時檢驗 (POCT) 設備在患者護理現場或附近提供快速診斷結果方面發揮著至關重要的作用，顯著增強了各種醫療保健環境中的臨床決策能力。這些測試廣泛用於管理慢性病、傳染病和緊急護理
- GSA 和比荷盧地區對 POCT 解決方案的需求主要源於慢性病負擔加重、老齡人口增長以及對分散式和以患者為中心的醫療保健模式的強烈推動
- 預計德國將以28.04% 的份額佔據該地區 POCT 市場的主導地位，這得益於其完善的醫療基礎設施、高診斷吞吐量以及採用先進的醫療技術
- 預計比荷盧三國市場將出現強勁增長，這得益於政府的積極舉措、醫療支出的增加以及臨床和家庭護理環境中 POCT 的日益普及
- 預計血糖檢測領域將以 34.08% 的份額引領該地區的 POCT 市場，這得益於糖尿病的高盛行率以及對幫助患者進行疾病管理的即時監測工具的需求
報告範圍和即時診斷（POCT）市場細分
|
屬性 |
眼科手術顯微鏡關鍵市場洞察 |
|
涵蓋的領域 |
|
|
覆蓋國家 |
總務管理局
比荷盧經濟聯盟
|
|
主要市場參與者 |
|
|
市場機會 |
|
|
加值資料資訊集 |
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。 |
即時檢驗 (POCT) 市場趨勢
“GSA和比荷盧三國在快速診斷和分散檢測方面取得的進展”
- 影響 GSA 和比荷盧地區 POCT 市場的一個突出趨勢是即時診斷設備中數位連接、微型感測器和多重測試功能的日益集成
- 這些創新提高了診斷速度和準確性，使醫療保健提供者能夠及時做出決策，特別是在緊急情況、慢性病管理和傳染病篩檢方面
- 例如，配備無線資料傳輸和電子健康記錄 (EHR) 整合的 POCT 系統在德國和荷蘭的初級保健機構中越來越多地使用，以簡化患者監測並減少醫院就診次數
- 這些進步正在徹底改變分散式診斷，支持基於價值的護理模式，並加速 GSA 和比荷盧三國地區向以患者為中心的醫療保健的轉變
- 預防性醫療保健日益受到重視，加上政府對早期疾病檢測的大力支持，持續推動對具有增強分析性能和可用性的下一代 POCT 解決方案的需求
即時檢驗（POCT）市場動態
司機
“醫療機構中 POC 檢測的使用日益增多”
- 醫療機構越來越多地使用即時檢驗 (POC)，這徹底改變了醫療服務提供者診斷和管理疾病的方式
- 隨著對快速且準確的診斷結果的需求不斷增加，醫療保健專業人員正在轉向 POC 測試來加強對患者的護理。這種轉變在急診室、門診和診斷中心尤為明顯，因為快速決策至關重要
- POC 檢測使醫療保健提供者能夠在護理點立即獲得結果，無需患者等待實驗室結果，從而顯著縮短診斷和治療時間
- 此外，POC 測試具有高度便攜性和用戶友好性，非常適合在從鄉村診所到大型醫院等各種醫療環境中使用
- 慢性病盛行率的上升和對高效醫療保健解決方案的需求不斷增長，進一步推動了 POC 測試的採用，因為它能夠更好地監測疾病，特別是在糖尿病、心血管疾病和傳染病等疾病中
- 隨著醫療機構越來越多地將這些技術納入其工作流程，對即時檢驗的需求持續成長，成為市場擴張的關鍵驅動力
例如，
- 2024 年 3 月，根據 NCBI 的數據，POCT 的快速週轉時間增強了臨床決策能力，減少了管理時間，並提高了分流效率，尤其是在急診室 (ED)。它的靈活性延伸至院前環境、野戰醫院以及災難期間、大型集會期間或擁擠地區。
- 2024 年 11 月，根據 OBJECTIVE Investment Banking & Valuation 發表的文章，向即時檢驗 (POCT) 的轉變透過將診斷直接帶到患者護理地點，徹底改變了醫療保健。它的速度、便利性和效率使其在急診、門診和遠端環境中具有不可估量的價值。隨著快速診斷需求的成長
- 醫療機構越來越多地採用即時檢驗 (POC) 來改變疾病的診斷和管理。由於需要快速、準確的結果，醫療保健提供者正在利用 POC 檢測來改善患者護理
機會
“提高對即時檢驗的認識和倡導”
- 隨著醫療保健專業人士、政策制定者和公眾對 POCT 的優勢（例如快速獲得結果、改善患者管理、縮短週轉時間以及分散檢測的潛力）的了解越來越多，對這些解決方案的需求也日益增長
- 患者團體、專業組織和行業機構的倡導工作進一步強調了 POCT 在各種臨床環境中的價值，包括急診、初級保健，甚至社區環境
- 這種理解和支持的增加轉化為更大的意願來投資並將 POCT 整合到現有的醫療保健工作流程中，從而透過推動採用和利用率的提高來擴大市場規模和覆蓋範圍
例如，
- 2023 年 4 月，NCBI 表示，絕大多數德國全科醫生 (GP)（高達 93%）認為即時檢驗 (POCT) 是其實踐中有價值的診斷工具。他們主要指出，能夠立即做出患者管理決策和提高診斷確定性是使用 POCT 的主要優勢
- 根據開放儲存庫發布的一篇題為《荷蘭初級保健中的即時診斷測試》的文章，醫療保健專業人員越來越多地利用即時診斷測試 (POC) 來做出治療決策。這些測試的主要優點是能夠直接在患者所在位置或附近快速提供結果
- 此外，這種增強的認識和倡導可以帶來有利的政策變革和資金舉措，從而支持更廣泛地實施 POCT。南非和比荷盧三國的政府和醫療保健系統認識到 POCT 在提高診斷效率和可近性的潛力，可能會分配更多資源來採用這些技術
- 倡議還可以影響監管機構簡化創新 POCT 設備的審批流程，加速其進入市場。這為市場成長創造了更有利的環境，鼓勵老牌企業和新進業者投資開發和部署先進的 POCT 解決方案，以滿足日益增長的需求
克制/挑戰
“資料安全和隱私問題”
- 隨著越來越多的 POCT 設備與數位平台集成，敏感患者資訊的收集、傳輸和儲存會增加未經授權的存取和資料外洩的風險。醫療保健資料（包括個人醫療詳細資料）需要根據 HIPAA 和 GDPR 等法律進行嚴格保護，這給製造商和醫療保健提供者帶來了額外的合規複雜性。
- 一些 POCT 設備缺乏強大的安全框架和加密協議，進一步加劇了這些擔憂。
- 此外，由於隱私風險，患者不願分享醫療數據，這可能會阻礙其廣泛採用，尤其是在對數位健康解決方案信任有限的地區。持續開發安全且符合隱私要求的系統至關重要，但當前的擔憂卻起到了限製作用，減緩了 GSA 和比荷盧 POCT 市場的創新和採用步伐
例如，
- 2021 年 7 月，根據 MDPI 發布的博客，在網路安全和隱私風險方面需要考慮的一個相關方面是已在醫院廣泛使用的醫療保健即時診斷 (POC) 系統。 POC 系統是結合設備和應用程式來收集、處理和視覺化資料的平台。使用在各種 POC 系統、後端分析平台、用戶工作站和智慧型手機之間傳輸的包含個人健康資訊和敏感醫療數據的大量數據，很明顯存在多種威脅，會導致數據洩露或危害患者生命的違規事件。即時檢測容易受到資料外洩的影響，限制了市場的成長
- 資料安全和隱私問題是 GSA 和比荷盧三國即時檢驗 (POCT) 市場的主要挑戰。隨著越來越多的設備連接到數位平台，未經授權存取和資料外洩的風險也隨之增加，尤其是對於敏感的患者資訊。遵守 HIPAA 和 GDPR 等法規為製造商和醫療保健提供者增加了複雜性。某些設備缺乏強大的安全性以及患者對隱私的擔憂可能會減緩其採用速度，尤其是在對數位健康解決方案信任度有限的地區。開發安全、符合隱私的系統對於克服這些障礙至關重要。
即時檢驗 (POCT) 市場範圍
市場根據應用、產品類型、技術、放大類型、最終用戶和分銷管道進行細分。
|
分割 |
細分 |
|
依產品類型 |
|
|
按平台 |
|
|
按應用 |
|
|
按處方模式
|
|
|
按最終用戶 |
|
|
按分銷管道
|
|
2025 年，血糖監測產品預計將佔據市場主導地位，在產品類型細分市場中佔有最大份額
由於糖尿病盛行率高，且經常需要方便、即時的血糖檢測，預計到 2025 年，血糖監測產品領域將佔據即時檢測 (POCT) 市場的主導地位，佔據 34.08% 的最大份額
預計橫向流動分析/免疫層析測試將在預測期內佔據平台部分的最大份額
2025 年，橫向流動分析/免疫層析測試領域預計將佔據市場主導地位，市場份額最大，為 37.28%，這得益於其簡單性、快速的結果、成本效益以及適用於傳統實驗室環境之外的廣泛診斷應用
即時檢驗（POCT）市場區域分析
“德國在即時診斷（POCT）市場佔有最大份額”
- 在 GSA 地區，德國佔據即時診斷 (POCT) 市場的主導地位，佔有 82.06% 的份額，這得益於其高度發達的醫療保健基礎設施、廣泛採用的創新診斷技術以及對預防和個性化醫療的高度重視
- 由於對快速且準確的診斷解決方案的需求不斷增長，特別是在管理糖尿病、心血管疾病和呼吸道感染等慢性病方面，中國佔據了相當大的份額。
- 支持性報銷框架、政府支持的數位健康計劃以及對醫療研發的強勁投資進一步促進了市場成長
- 此外，POCT 在急診、初級保健機構和家庭醫療保健中的應用日益廣泛，加上對減輕醫院負擔的重視，正在推動德國市場擴張
“荷蘭預計將在即時診斷（POCT）市場實現最高複合年增長率”
- 荷蘭預計將在即時診斷檢測 (POCT) 市場實現強勁增長，市場份額將達到 54.40%，這得益於荷蘭高度重視數位醫療、早期疾病檢測和以患者為中心的護理模式
- 該國人口老化以及糖尿病、心血管疾病和呼吸系統疾病等慢性病的盛行率不斷上升，推動了快速、分散診斷解決方案的需求
- 荷蘭擁有完善的初級保健體系和先進的醫療政策，仍然是 POCT 技術的主要採用者，尤其是在社區健康機構、全科醫生 (GP) 診所和家庭護理服務領域
- POCT 設備與電子健康記錄 (EHR) 的日益融合、醫療保險公司對診斷創新的支持以及歐盟範圍內健康技術計劃的積極參與，進一步增強了市場前景
- 學術機構、科技新創公司和診斷公司之間的合作正在加速針對荷蘭醫療保健體系的先進、用戶友好的 POCT 解決方案的創新和本地開發
即時檢驗（POCT）市場佔有率
市場競爭格局提供了競爭對手的詳細資訊。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投資、新市場計劃、全球影響力、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度、應用優勢。以上提供的數據點僅與公司對市場的關注有關。
市場中主要的市場領導者有：
- F. Hoffmann-La Roche Ltd（瑞士）
- 丹納赫公司（美國）
- 西門子醫療股份公司（德國）
- Bio-Rad Laboratories, Inc.（美國）
- 生物梅里埃（法國）
- BD（美國）
- QuidelOrtho Corporation（美國）
- Hologic公司（美國）
- 賽默飛世爾科技公司（美國）
- 雅培（美國）
- 韋爾芬（西班牙）
- QIAGEN（德國）
- Sysmex株式會社（日本）
- EKF Diagnostics Holdings plc. （英國）
- Sekisui Diagnostics（美國）
- Meridian Bioscience（美國）
- binx 健康公司（們）
- Trinity Biotech（愛爾蘭）
- Sienco, Inc.（美國）
- ACCUBIOTECH 有限公司（中國）
GSA 和比荷盧三國即時診斷 (POCT) 市場的最新發展
- 2023 年 12 月，羅氏收購了 LumiraDx 創新的即時診斷技術的部分內容，增強了其診斷產品組合。此次收購使得針對多個疾病領域的檢測更快、更經濟實惠。 LumiraDx 平台的整合將改善全球分散醫療環境中病患獲得及時、準確診斷結果的機會
- 2025年1月，丹納赫集團與醫療保健AI公司Innovaccer Inc.建立投資夥伴關係。此次合作旨在透過為醫療保健提供者提供統一的患者數據和高級分析，加速精準診斷和基於價值的護理的採用，並透過個人化、及時的干預改善患者治療結果
- 2024 年 10 月，生物梅里埃呼籲多部門合作，推動抗菌素抗藥性 (AMR) 全球議程。該公司強調，迫切需要醫療保健、政府和產業共同努力解決抗菌藥物抗藥性問題，推廣創新的診斷解決方案和負責任的抗菌藥物使用，以應對這一日益嚴重的全球健康威脅
- 2024 年 3 月，Bio-Rad 推出 XP-Design Assay 沙門氏菌血清分型解決方案，用於快速且準確的食品安全檢測。 XP-Design Assay 沙門氏菌血清分型解決方案提供了一種靈活的方法來在初步篩選後識別沙門氏菌血清型。即用型溶液含有針對目標血清型的寡核苷酸（引子和探針），可確保高特異性並降低交叉反應的風險，從而提供可靠的結果
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 CURRENCY AND PRICING
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELLING
2.6 PRODUCT TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 MICRO AND MACRO ECONOMIC FACTORS
4.4 PENETRATION AND GROWTH PROSPECT MAPPING
4.5 KEY PRICING STRATEGIES
4.6 COST ANALYSIS BREAKDOWN
4.7 OPPORTUNITY MAP ANALYSIS
4.8 VALUE CHAIN ANALYSIS
4.9 HEALTHCARE ECONOMY
4.1 TARIFFS
4.10.1 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR
4.10.2 GLOBAL VS. REGIONAL TARIFF STRUCTURES
4.10.3 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY
4.10.4 TARIFF REGULATIONS IN KEY MARKETS
4.10.4.1 MEDICARE/MEDICAID TARIFF POLICIES
4.10.4.2 CMS PRICING MODELS
4.10.4.3 OTHERS
4.10.5 TARIFFS ON MEDICAL DEVICES & EQUIPMENT
4.10.5.1 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT
4.10.5.2 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY
4.10.5.3 CASE STUDIES OF TARIFF CHANGES AFFECTING THE INDUSTRY
4.10.6 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES
4.10.7 TARIFF EXEMPTIONS AND INCENTIVES
4.10.8 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES
4.10.9 16.9 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN
4.10.10 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS
5 CUSTOMIZATION
5.1 LEADING DIGITAL HEALTH PLATFORMS IN EACH COUNTRY –
5.2 POCT DATA INTEGRATION USE CASES –
5.3 INFORMATICS PLATFORMS & TELEMEDICINE INTEGRATION:
6 REGULATORY
6.1 REGULATORY GSA
6.2 REGULATORY BENELUX
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES
7.1.2 RISING INCIDENCE OF SUBSTANCE ABUSE
7.1.3 INCREASED ADOPTION OF TELEMEDICINE
7.1.4 ADVANCEMENTS TECHNOLOGIES ENHANCING POC TESTING WITH BIOSENSORS AND MOBILE INTEGRATION
7.2 RESTRAINTS
7.2.1 DATA SECURITY AND PRIVACY CONCERNS
7.2.2 ACCURACY LIMITATIONS AND TECHNICAL BARRIERS
7.3 OPPORTUNITIES
7.3.1 RISING AWARENESS AND ADVOCACY FOR POINT-OF-CARE TESTING
7.3.2 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS
7.3.3 EXPANDING PRODUCT RANGE FOR POINT-OF-CARE TESTING
7.4 CHALLENGES
7.4.1 LIMITED AWARENESS AND ACCEPTANCE OF POINT-OF-CARE (POC) TESTING
7.4.2 IMPACT OF HIGH MAINTENANCE COSTS THREATEN POINT-OF-CARE TESTING (POCT) SUSTAINABILITY IN LOW-RESOURCE SETTINGS
8 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 GLUCOSE MONITORING PRODUCTS
8.2.1 STRIPS
8.2.2 METERS
8.2.3 LANCETS AND LANCING DEVICES
8.3 INFECTIOUS DISEASE TESTING PRODUCTS
8.3.1 COVID-19
8.3.2 HIV TESTING PRODUCTS
8.3.2.1 TESTING REAGENTS
8.3.2.2 TESTING EQUIPMENT
8.3.3 RESPIRATORY INFECTION TESTING PRODUCTS
8.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING
8.3.4.1 NAAT-BASED SYSTEMS
8.3.4.2 NON–NAAT-BASED SYSTEMS
8.3.5 HEPATITIS C TESTING PRODUCTS
8.3.5.1 HCV ANTIBODY TESTS
8.3.5.2 HCV VIRAL LOAD TESTS
8.3.6 INFLUENZA TESTING PRODUCTS
8.3.6.1 TRADITIONAL DIAGNOSTIC TEST
8.3.6.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)
8.3.6.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)
8.3.6.1.3 VIRAL CULTURE
8.3.6.1.4 SEROLOGICAL ASSAY
8.3.6.2 MOLECULAR DIAGNOSTIC ASSAY
8.3.6.2.1 RT-PCR
8.3.6.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)
8.3.6.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)
8.3.6.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)
8.3.7 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING
8.3.8 TROPICAL DISEASE TESTING PRODUCTS
8.3.9 OTHER INFECTIOUS DISEASE TESTING PRODUCTS
8.4 CARDIOMETABOLIC MONITORING PRODUCTS
8.4.1 CARDIAC MARKER TESTING PRODUCTS
8.4.1.1 HSTNL
8.4.1.2 BNP
8.4.1.3 D-DIMER
8.4.1.4 CK-MB
8.4.1.5 MYOGLOBIN
8.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
8.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES
8.4.3.1 CARTRIDGES
8.4.3.2 REAGENTS
8.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS
8.4.4.1 PORTABLE
8.4.4.1.1 COMBINED ANALYZERS
8.4.4.1.2 BLOOD GAS ANALYZERS
8.4.4.1.3 ELECTROLYTE ANALYZERS
8.4.4.2 BENCHTOP
8.4.4.2.1 COMBINED ANALYZERS
8.4.4.2.2 BLOOD GAS ANALYZERS
8.4.4.2.3 ELECTROLYTE ANALYZERS
8.4.5 HBA1C TESTING PRODUCTS
8.4.5.1 HBA1C TESTING INSTRUMENTS
8.4.5.2 HBA1C TESTING CONSUMABLES
8.4.6 POC ANALYZER
8.4.7 ECG DEVICE
8.4.7.1 RESTING ECG DEVICES
8.4.7.2 STRESS ECG DEVICES
8.4.7.3 HOLTER MONITORS
8.5 PREGNANCY AND FERTILITY TESTING PRODUCTS
8.5.1 PREGNANCY TESTING PRODUCTS
8.5.1.1 STRIPS/ DIP STICKS AND CARDS
8.5.1.2 MID STREAM DEVICES
8.5.1.3 CASSETTES
8.5.1.4 DIGITAL DEVICES
8.5.1.5 LINE-INDICATOR DEVICES
8.5.2 FERTILITY TESTING PRODUCTS
8.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST
8.5.2.2 FSH TEST
8.5.2.3 OTHERS
8.6 HAEMATOLOGY TESTING PRODUCTS
8.7 COAGULATION MONITORING PRODUCTS
8.7.1 ANTICOAGULATION MONITORING DEVICES
8.7.1.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES
8.7.1.2 ACTIVATED CLOTTING TIME (ACT)
8.7.1.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)
8.7.2 PLATELET FUNCTION MONITORING DEVICES
8.7.3 VISCOELASTIC COAGULATION MONITORING DEVICES
8.7.3.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)
8.7.3.2 THROMBOELASTOGRAPHY (TEG)
8.8 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS
8.8.1 DOA ANALYSERS
8.8.1.1 IMMUNOASSAYS
8.8.1.2 CHROMATOGRAPHIC DEVICES
8.8.1.3 BREATH ANALYSERS
8.8.2 RAPID TESTING DEVICES
8.8.2.1 URINE TESTING DEVICES
8.8.2.2 ORAL FLUID TESTING DEVICES
8.8.2.3 OTHERS
8.9 URINALYSIS TESTING PRODUCTS
8.9.1 POC URINE STRIP SELF-TESTING
8.9.2 POC URINE TEST STRIP PROFESSIONAL TESTING
8.1 CHOLESTEROL TESTING PRODUCTS
8.10.1 TESTING KITS
8.10.2 INSTRUMENTS
8.10.2.1 TABLE-TOP ANALYZERS
8.10.2.2 HAND-HELD ANALYZERS
8.11 TUMOR/CANCER MARKER TESTING PRODUCTS
8.12 FECAL OCCULT TESTING PRODUCTS
8.12.1 GUAIAC FOB STOOL TEST
8.12.2 LATERAL FLOW IMMUNO-FOB TEST
8.12.3 IMMUNO-FOB AGGLUTINATION TEST
8.12.4 IMMUNO-FOB ELISA TEST
8.13 OTHERS
9 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE
9.1 OVERVIEW
9.2 OTC TESTING
9.3 PRESCRIPTION-BASED TESTING
10 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM
10.1 OVERVIEW
10.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS
10.3 IMMUNOASSAYS
10.4 DIPSTICKS
10.5 MOLECULAR DIAGNOSTICS
10.6 CLINICAL CHEMISTRY ASSAYS
10.7 MICROFLUIDICS
10.8 HEMATOLOGY
10.9 OTHERS
11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 BLOOD GLUCOSE
11.3 INFECTIOUS DISEASES
11.3.1 COVID-19 TESTING
11.3.2 HIV TESTING
11.3.3 HEPATITIS C TESTING
11.3.4 INFLUENZA TESTING
11.3.5 TUBERCULOSIS TESTING
11.3.6 OTHERS
11.4 VITAL SIGN MONITORING
11.5 CARDIAC MONITORING
11.6 COAGULATION
11.7 HAEMATOLOGY
11.8 NON- INVASIVE SPO2 MONITORING
11.9 BLOOD TRANSFUSION
11.1 NON- INVASIVE PCO2 MONITORING
11.11 WHOLE BLOOD ANALYSIS
11.12 OTHERS
12 GSA POINT-OF-CARE TESTING (POCT) MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PRIVATE
12.2.1.1 TIER 1
12.2.1.2 TIER 2
12.2.1.3 TIER 3
12.2.2 PUBLIC
12.3 HOME CARE
12.4 CLINICS
12.5 LABORATORIES
12.6 DIAGNOSTIC CENTERS
12.7 PATHOLOGY LABS
12.8 AMBULATORY SURGERY CENTERS
12.9 ELDERLY CARE CENTERS
12.1 OTHERS
13 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 ONLINE SALES
13.5 OTHERS
14 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE
14.1 OVERVIEW
14.2 GLUCOSE MONITORING PRODUCTS
14.2.1 STRIPS
14.2.2 METERS
14.2.3 LANCETS AND LANCING DEVICES
14.3 INFECTIOUS DISEASE TESTING PRODUCTS
14.3.1 COVID-19
14.3.2 HIV TESTING PRODUCTS
14.3.2.1 TESTING REAGENTS
14.3.2.2 TESTING EQUIPMENT
14.3.3 RESPIRATORY INFECTION TESTING PRODUCTS
14.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING
14.3.5 NAAT-BASED SYSTEMS
14.3.6 NON–NAAT-BASED SYSTEMS
14.3.7 HEPATITIS C TESTING PRODUCTS
14.3.7.1 HCV ANTIBODY TESTS
14.3.7.2 HCV VIRAL LOAD TESTS
14.3.8 INFLUENZA TESTING PRODUCTS
14.3.8.1 TRADITIONAL DIAGNOSTIC TEST
14.3.8.1.1 RAPID INFLUENZA DIAGNOSTIC TEST (RIDT)
14.3.8.1.2 DIRECT FLUORESCENT ANTIBODY TEST (DFAT)
14.3.8.1.3 VIRAL CULTURE
14.3.8.1.4 SEROLOGICAL ASSAY
14.3.8.2 MOLECULAR DIAGNOSTIC ASSAY
14.3.8.2.1 RT-PCR
14.3.8.2.2 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAY (LAMP)
14.3.8.2.3 NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION TEST (NASBAT)
14.3.8.2.4 SIMPLE AMPLIFICATION-BASED ASSAY (SAMBA)
14.3.9 HEALTHCARE ASSOCIATED INFECTION (HAI) TESTING
14.3.10 TROPICAL DISEASE TESTING PRODUCTS
14.3.11 OTHER INFECTIOUS DISEASE TESTING PRODUCTS
14.4 CARDIOMETABOLIC MONITORING PRODUCTS
14.4.1 CARDIAC MARKER TESTING PRODUCTS
14.4.1.1 HSTNL
14.4.1.2 BNP
14.4.1.3 D-DIMER
14.4.1.4 CK-MB
14.4.1.5 MYOGLOBIN
14.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS
14.4.3 BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES
14.4.3.1 CARTRIDGES
14.4.3.2 REAGENTS
14.4.4 BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS
14.4.5 PORTABLE
14.4.5.1 COMBINED ANALYZERS
14.4.5.2 BLOOD GAS ANALYZERS
14.4.5.3 ELECTROLYTE ANALYZERS
14.4.6 BENCHTOP
14.4.6.1 COMBINED ANALYZERS
14.4.6.2 BLOOD GAS ANALYZERS
14.4.6.3 ELECTROLYTE ANALYZERS
14.4.7 HBA1C TESTING PRODUCTS
14.4.7.1 HBA1C TESTING INSTRUMENTS
14.4.7.2 HBA1C TESTING CONSUMABLES
14.4.8 POC ANALYZER
14.4.9 ECG DEVICE
14.4.9.1 RESTING ECG DEVICES
14.4.9.2 STRESS ECG DEVICES
14.4.9.3 HOLTER MONITORS
14.5 PREGNANCY AND FERTILITY TESTING PRODUCTS
14.5.1 PREGNANCY TESTING PRODUCTS
14.5.1.1 STRIPS/ DIP STICKS AND CARDS
14.5.1.2 MID STREAM DEVICES
14.5.1.3 CASSETTES
14.5.1.4 DIGITAL DEVICES
14.5.1.5 LINE-INDICATOR DEVICES
14.5.2 FERTILITY TESTING PRODUCTS
14.5.2.1 LUTEINIZING HORMONE (LH) URINE TEST
14.5.2.2 FSH TEST
14.5.2.3 OTHERS
14.6 HAEMATOLOGY TESTING PRODUCTS
14.7 COAGULATION MONITORING PRODUCTS
14.8 ANTICOAGULATION MONITORING DEVICES
14.8.1 PROTHROMBIN TIME/INTERNATIONAL NORMALIZED RATIO (PT-INR) TESTING DEVICES
14.8.2 ACTIVATED CLOTTING TIME (ACT)
14.8.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APPT)
14.8.4 PLATELET FUNCTION MONITORING DEVICES
14.8.5 VISCOELASTIC COAGULATION MONITORING DEVICES
14.8.5.1 ROTATIONAL THROMBOELASTOMETRY (ROTEM)
14.8.5.2 THROMBOELASTOGRAPHY (TEG)
14.9 DRUG-OF-ABUSE (DOA) TESTING PRODUCTS
14.9.1 DOA ANALYSERS
14.9.1.1 IMMUNOASSAYS
14.9.1.2 CHROMATOGRAPHIC DEVICES
14.9.1.3 BREATH ANALYSERS
14.9.2 RAPID TESTING DEVICES
14.9.2.1 URINE TESTING DEVICES
14.9.2.2 ORAL FLUID TESTING DEVICES
14.9.3 OTHERS
14.1 URINALYSIS TESTING PRODUCTS
14.10.1 POC URINE STRIP SELF-TESTING
14.10.2 POC URINE TEST STRIP PROFESSIONAL TESTING
14.11 CHOLESTEROL TESTING PRODUCTS
14.11.1 TESTING KITS
14.11.2 INSTRUMENTS
14.11.2.1 TABLE-TOP ANALYZERS
14.11.2.2 HAND-HELD ANALYZERS
14.12 TUMOR/CANCER MARKER TESTING PRODUCTS
14.13 FECAL OCCULT TESTING PRODUCTS
14.13.1 GUAIAC FOB STOOL TEST
14.13.2 LATERAL FLOW IMMUNO-FOB TEST
14.13.3 IMMUNO-FOB AGGLUTINATION TEST
14.13.4 IMMUNO-FOB ELISA TEST
14.14 OTHERS
15 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM
15.1 OVERVIEW
15.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS
15.3 IMMUNOASSAYS
15.4 DIPSTICKS
15.5 MOLECULAR DIAGNOSTICS
15.6 CLINICAL CHEMISTRY ASSAYS
15.7 MICROFLUIDICS
15.8 HEMATOLOGY
15.9 OTHERS
16 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE
16.1 OVERVIEW
16.2 OTC TESTING
16.3 PRESCRIPTION-BASED TESTING
17 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION
17.1 OVERVIEW
17.2 BLOOD GLUCOSE
17.3 INFECTIOUS DISEASES
17.3.1.1 COVID-19 TESTING
17.3.1.2 HIV TESTING
17.3.1.3 HEPATITIS C TESTING
17.3.1.4 INFLUENZA TESTING
17.3.1.5 TUBERCULOSIS TESTING
17.3.1.6 OTHERS
17.4 VITAL SIGN MONITORING
17.5 CARDIAC MONITORING
17.6 COAGULATION
17.7 HAEMATOLOGY
17.8 NON- INVASIVE SPO2 MONITORING
17.9 BLOOD TRANSFUSION
17.1 NON- INVASIVE PCO2 MONITORING
17.11 WHOLE BLOOD ANALYSIS
17.12 OTHERS
18 BENELUX POINT-OF-CARE TESTING (POCT) MARKET, BY END USER
18.1 OVERVIEW
18.2 HOSPITALS
18.2.1 PRIVATE
18.2.1.1 TIER 1
18.2.1.2 TIER 2
18.2.1.3 TIER 3
18.2.2 PUBLIC
18.3 HOME CARE
18.4 CLINICS
18.5 LABORATORIES
18.6 DIAGNOSTIC CENTERS
18.7 PATHOLOGY LABS
18.8 AMBULATORY SURGERY CENTERS
18.9 ELDERLY CARE CENTERS
18.1 OTHERS
19 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL
19.1 OVERVIEW
19.2 DIRECT TENDER
19.3 RETAIL SALES
19.4 ONLINE SALES
19.5 OTHERS
20 GSA & BENELUX
20.1 GERMANY
20.2 NETHERLANDS
20.3 SWITZERLAND
20.4 BELGIUM
20.5 AUSTRIA
20.6 LUXEMBOURG
21 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY LANDSCAPE
21.1 COMPANY SHARE ANALYSIS: GSA AND BENELUX
22 SWOT ANALYSIS
23 COMPANY PROFILE
23.1 F. HOFFMANN-LA ROCHE LTD
23.1.1 COMPANY SNAPSHOT
23.1.2 REVENUE ANALYSIS
23.1.3 PRODUCT PORTFOLIO
23.1.4 RECENT DEVELOPMENT
23.2 DANAHER CORPORATION
23.2.1 COMPANY SNAPSHOT
23.2.2 REVENUE ANALYSIS
23.2.3 PRODUCT PORTFOLIO
23.2.4 RECENT DEVELOPMENT
23.3 SIEMENS HEALTHINEERS AG
23.3.1 COMPANY SNAPSHOT
23.3.2 REVENUE ANALYSIS
23.3.3 PRODUCT PORTFOLIO
23.3.4 RECENT DEVELOPMENT
23.4 BIO- RAD LABORATORIES, INC.
23.4.1 COMPANY SNAPSHOT
23.4.2 REVENUE ANALYSIS
23.4.3 PRODUCT PORTFOLIO
23.4.4 RECENT DEVELOPMENT
23.5 BIOMERIEUX
23.5.1 COMPANY SNAPSHOT
23.5.2 REVENUE ANALYSIS
23.5.3 PRODUCT PORTFOLIO
23.5.4 RECENT DEVELOPMENT
23.6 ACCUBIOTECH CO., LTD.
23.6.1 COMPANY SNAPSHOT
23.6.2 PRODUCT PORTFOLIO
23.6.3 RECENT DEVELOPMENT
23.7 ABBOTT
23.7.1 COMPANY SNAPSHOT
23.7.2 REVENUE ANALYSIS
23.7.3 PRODUCT PORTFOLIO
23.7.4 RECENT DEVELOPMENT/NEWS
23.8 BINX HEALTH
23.8.1 COMPANY SNAPSHOT
23.8.2 SOLUTION PORTFOLIO
23.8.3 RECENT DEVELOPMENT
23.9 BD
23.9.1 COMPANY SNAPSHOT
23.9.2 REVENUE ANALYSIS
23.9.3 PRODUCT PORTFOLIO
23.9.4 RECENT DEVELOPMENT/NEWS
23.1 EKF DIAGNOSTICS HOLDINGS PLC
23.10.1 COMPANY SNAPSHOT
23.10.2 REVENUE ANALYSIS
23.10.3 PRODUCT PORTFOLIO
23.10.4 RECENT DEVELOPMENT
23.11 HOLOGIC, INC
23.11.1 COMPANY SNAPSHOT
23.11.2 REVENUE ANALYSIS
23.11.3 PRODUCT PORTFOLIO
23.11.4 RECENT DEVELOPMENT
23.12 MERIDIAN BIOSCIENCE, INC.
23.12.1 COMPANY SNAPSHOT
23.12.2 PRODUCT PORTFOLIO
23.12.3 RECENT DEVELOPMENT/NEWS
23.13 QIAGEN
23.13.1 COMPANY SNAPSHOT
23.13.2 REVENUE ANALYSIS
23.13.3 PRODUCT PORTFOLIO
23.13.4 RECENT DEVELOPMENT
23.14 QUIDELORTHO CORPORATION
23.14.1 COMPANY SNAPSHOT
23.14.2 REVENUE ANALYSIS
23.14.3 PRODUCT PORTFOLIO
23.14.4 RECENT DEVELOPMENT
23.15 SEKISUI DIAGNOSTICS
23.15.1 COMPANY SNAPSHOT
23.15.2 PRODUCT PORTFOLIO
23.15.3 RECENT DEVELOPMENT
23.16 SYSMEX CORPORATION
23.16.1 COMPANY SNAPSHOT
23.16.2 REVENUE ANALYSIS
23.16.3 PRODUCT PORTFOLIO
23.16.4 RECENT DEVELOPMENT
23.17 SIENCO, INC.
23.17.1 COMPANY SNAPSHOT
23.17.2 PRODUCT PORTFOLIO
23.17.3 RECENT DEVELOPMENT
23.18 TRINITY BIOTECH
23.18.1 COMPANY SNAPSHOT
23.18.2 REVENUE ANALYSIS
23.18.3 PRODUCT PORTFOLIO
23.18.4 RECENT DEVELOPMENT
23.19 THERMO FISHER SCIENTIFIC INC.
23.19.1 COMPANY SNAPSHOT
23.19.2 REVENUE ANALYSIS
23.19.3 PRODUCT PORTFOLIO
23.19.4 RECENT DEVELOPMENT
23.2 WERFEN
23.20.1 COMPANY SNAPSHOT
23.20.2 PRODUCT PORTFOLIO
23.20.3 RECENT DEVELOPMENT
24 QUESTIONNAIRE
表格列表
TABLE 1 HOME-USE POCT DEVICES WITH TELEMEDICINE INTEGRATION
TABLE 2 COMPANIES AND PRODUCTS WITH TELEMEDICINE INTEGRATION
TABLE 3 A TECHNOLOGY ROADMAP OUTLINING THE FUTURE OF CONNECTED POCT DEVICES
TABLE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 6 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 7 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 9 GSA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 10 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 12 GSA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 13 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 15 GSA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 16 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 17 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 18 GSA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 19 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 21 GSA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 22 GSA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 24 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 25 GSA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 26 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 28 GSA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 29 GSA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 31 GSA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 32 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 34 GSA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 35 GSA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 36 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 38 GSA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 39 GSA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 40 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 42 GSA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 43 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 45 GSA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 46 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 48 GSA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 49 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 50 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 51 GSA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 52 GSA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 53 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 54 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 55 GSA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 56 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 58 GSA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 59 GSA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 62 GSA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 63 GSA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 64 GSA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 GSA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)
TABLE 67 GSA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 68 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 69 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 70 GSA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 71 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 73 GSA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 74 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 76 GSA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 77 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 79 GSA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 80 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 82 GSA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 83 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 84 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 85 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 86 GSA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 88 GSA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 GSA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 90 GSA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 91 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 92 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 94 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 95 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 97 BENELUX GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 98 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 100 BENELUX INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 101 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 102 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 103 BENELUX HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 104 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 106 BENELUX SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 107 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 109 BENELUX HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 110 BENELUX INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 112 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 113 BENELUX TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 114 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 116 BENELUX MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 117 BENELUX CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 119 BENELUX POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 120 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 122 BENELUX CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 123 BENELUX BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 BENELUX BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 127 BENELUX BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 130 BENELUX PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 131 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 133 BENELUX BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 134 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 136 BENELUX HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 137 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 139 BENELUX ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 140 BENELUX PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 143 BENELUX PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 144 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 145 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 146 BENELUX FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 147 BENELUX COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 148 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 149 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 150 BENELUX ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 151 BENELUX VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 152 BENELUX DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 BENELUX DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNIT)
TABLE 155 BENELUX DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 156 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 158 BENELUX RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 159 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 160 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 161 BENELUX URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 162 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 164 BENELUX CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 165 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 166 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 167 BENELUX INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 168 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 170 BENELUX FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 171 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 172 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 173 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 174 BENELUX INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 175 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 176 BENELUX HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 BENELUX PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 178 BENELUX PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 179 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 180 GSA & BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 181 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 182 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 183 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 185 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 186 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 188 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 189 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 191 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 192 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 193 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 194 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 195 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 197 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 198 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 200 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 201 GERMANY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 204 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 205 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 206 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 207 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 208 GERMANY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 209 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 210 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 211 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 213 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 214 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 217 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 218 GERMANY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 220 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 221 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 222 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 224 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 225 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 227 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 228 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 230 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 231 GERMANY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 233 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 234 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 235 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 236 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 237 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 238 GERMANY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 241 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 242 GERMANY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 243 GERMANY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 244 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 245 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 246 GERMANY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 247 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 249 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 250 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 251 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 252 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 253 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 254 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 255 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 256 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 257 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 258 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 259 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 260 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 261 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 262 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 263 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 264 GERMANY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 266 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 267 GERMANY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 GERMANY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 269 GERMANY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 270 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 271 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 273 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 274 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 275 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 276 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 277 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 278 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 279 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 280 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 282 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 283 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 285 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 286 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 288 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 289 NETHERLANDS INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 291 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 292 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 293 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 294 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 295 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 296 NETHERLANDS CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 297 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 298 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 299 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 301 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 302 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 303 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 305 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 306 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 307 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 309 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 310 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 312 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 313 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 315 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 316 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 317 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 318 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 319 NETHERLANDS PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 320 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 322 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 323 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 325 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 326 NETHERLANDS COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 329 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 330 NETHERLANDS VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 331 NETHERLANDS DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 332 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 333 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 334 NETHERLANDS DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 335 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 336 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 337 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 338 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 339 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 340 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 341 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 342 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 343 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 344 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 345 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 346 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 347 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 348 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 349 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 350 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 351 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 352 NETHERLANDS INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 354 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 355 NETHERLANDS HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 NETHERLANDS PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 357 NETHERLANDS PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 358 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 359 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 361 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 362 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 363 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 364 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 365 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 367 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 368 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 369 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 370 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 371 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 373 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 374 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 375 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 376 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 377 SWITZERLAND INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 378 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 379 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 380 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 381 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 382 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 383 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 384 SWITZERLAND CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 386 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 387 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 388 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 389 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 390 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 391 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 392 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 393 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 394 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 396 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 397 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 398 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 400 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 401 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 403 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 404 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 406 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 407 SWITZERLAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 409 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 410 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 411 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 412 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 413 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 414 SWITZERLAND COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 415 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 417 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 418 SWITZERLAND VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 419 SWITZERLAND DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 420 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 421 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 422 SWITZERLAND DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 423 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 424 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 425 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 426 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 427 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 428 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 429 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 430 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 431 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 432 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 433 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 434 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 435 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 436 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 437 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 438 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 439 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 440 SWITZERLAND INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 442 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 443 SWITZERLAND HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 444 SWITZERLAND PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 445 SWITZERLAND PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 446 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 447 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 449 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 450 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 451 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 452 BELGIUM GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 453 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 454 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 455 BELGIUM INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 456 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 457 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 458 BELGIUM HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 459 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 460 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 461 BELGIUM SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 462 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 463 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 464 BELGIUM HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 465 BELGIUM INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 466 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 467 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 468 BELGIUM TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 469 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 470 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 471 BELGIUM MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 472 BELGIUM CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 473 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 474 BELGIUM POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 475 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 476 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 477 BELGIUM CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 478 BELGIUM BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 479 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 480 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 481 BELGIUM BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 482 BELGIUM BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 483 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 484 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 485 BELGIUM PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 486 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 487 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 488 BELGIUM BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 489 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 490 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 491 BELGIUM HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 492 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 493 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 494 BELGIUM ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 495 BELGIUM PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 496 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 497 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 498 BELGIUM PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 499 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 500 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 501 BELGIUM FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 502 BELGIUM COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 503 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 504 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 505 BELGIUM ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 506 BELGIUM VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 507 BELGIUM DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 508 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 509 BELGIUM DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 510 BELGIUM DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 511 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 512 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 513 BELGIUM RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 514 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 515 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 516 BELGIUM URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 517 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 518 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 519 BELGIUM CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 520 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 521 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 522 BELGIUM INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 523 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 524 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 525 BELGIUM FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 526 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 527 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 528 BELGIUM INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 529 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 530 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 531 BELGIUM HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 532 BELGIUM PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 533 BELGIUM PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 534 BELGIUM POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 535 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 536 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 537 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 538 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 539 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 540 AUSTRIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 541 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 542 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 543 AUSTRIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 544 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 545 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 546 AUSTRIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 547 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 548 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 549 AUSTRIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 550 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 551 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 552 AUSTRIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 553 AUSTRIA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 554 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 555 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 556 AUSTRIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 557 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 558 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 559 AUSTRIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 560 AUSTRIA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 561 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 562 AUSTRIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 563 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 564 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 565 AUSTRIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 566 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 567 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 568 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 569 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 570 AUSTRIA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 571 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 572 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 573 AUSTRIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 574 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 575 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 576 AUSTRIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 577 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 578 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 579 AUSTRIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 580 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 581 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 582 AUSTRIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 583 AUSTRIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 584 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 585 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 586 AUSTRIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 587 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 588 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 589 AUSTRIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 590 AUSTRIA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 591 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 592 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 593 AUSTRIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 594 AUSTRIA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 595 AUSTRIA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 596 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 597 AUSTRIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 598 AUSTRIA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 599 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 600 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 601 AUSTRIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 602 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 603 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 604 AUSTRIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 605 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 606 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 607 AUSTRIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 608 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 609 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 610 AUSTRIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 611 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 612 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 613 AUSTRIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 614 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 615 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 616 AUSTRIA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 617 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 618 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 619 AUSTRIA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 620 AUSTRIA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 621 AUSTRIA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 622 AUSTRIA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 623 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 624 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 625 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 626 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 627 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 628 LUXEMBOURG GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 629 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 630 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 631 LUXEMBOURG INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 632 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 633 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 634 LUXEMBOURG HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 635 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 636 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 637 LUXEMBOURG SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 638 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 639 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 640 LUXEMBOURG HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 641 LUXEMBOURG INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 642 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 643 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 644 LUXEMBOURG TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 645 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 646 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 647 LUXEMBOURG MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 648 LUXEMBOURG CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 649 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 650 LUXEMBOURG POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 651 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 652 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 653 LUXEMBOURG CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 654 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 655 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 656 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 657 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 658 LUXEMBOURG BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 659 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 660 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 661 LUXEMBOURG PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 662 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 663 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 664 LUXEMBOURG BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 665 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 666 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 667 LUXEMBOURG HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 668 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 669 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 670 LUXEMBOURG ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 671 LUXEMBOURG PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 672 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 673 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 674 LUXEMBOURG PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 675 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 676 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 677 LUXEMBOURG FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 678 LUXEMBOURG COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 679 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 680 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 681 LUXEMBOURG ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 682 LUXEMBOURG VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 683 LUXEMBOURG DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 684 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 685 LUXEMBOURG DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 686 LUXEMBOURG DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 687 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 688 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 689 LUXEMBOURG RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 690 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 691 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 692 LUXEMBOURG URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 693 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 694 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 695 LUXEMBOURG CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 696 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 697 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 698 LUXEMBOURG INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 699 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 700 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 701 LUXEMBOURG FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 702 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2032 (USD THOUSAND)
TABLE 703 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 704 LUXEMBOURG INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 705 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD THOUSAND)
TABLE 706 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 707 LUXEMBOURG HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 708 LUXEMBOURG PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 709 LUXEMBOURG PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 710 LUXEMBOURG POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
图片列表
FIGURE 1 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION
FIGURE 2 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DATA TRIANGULATION
FIGURE 3 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DROC ANALYSIS
FIGURE 4 GSA POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 6 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 7 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION
FIGURE 11 GSA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)
FIGURE 12 BEMELUX POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE (2024)
FIGURE 13 GSA POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY
FIGURE 14 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: EXECUTIVE SUMMARY
FIGURE 15 STRATEGIC DECISIONS
FIGURE 16 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE GSA POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 17 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET, IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 18 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GSA POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 19 GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BENELUX POINT-OF-CARE-TESTING (POCT) MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 20 DROC ANALYSIS
FIGURE 21 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE PREVALENCE (PERCENTAGE)
FIGURE 22 NUMBER OF PEOPLE USING VARIOUS SUBSTANCES OR EXPERIENCING PROBLEMATIC USE (IN MILLION)
FIGURE 23 SUBSTANCE USE BEHAVIOURS AMONG 15-YEAR-OLDS IN 2022 (SELF-REPORTED PREVALENCE)
FIGURE 24 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024
FIGURE 25 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)
FIGURE 26 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 27 GSA POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 28 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024
FIGURE 29 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)
FIGURE 30 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)
FIGURE 31 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE
FIGURE 32 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024
FIGURE 33 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)
FIGURE 34 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)
FIGURE 35 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 36 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024
FIGURE 37 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 38 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)..
FIGURE 39 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 40 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024
FIGURE 41 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 42 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)
FIGURE 43 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE
FIGURE 44 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 45 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 46 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)
FIGURE 47 GSA POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 48 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2024
FIGURE 49 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)
FIGURE 50 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 51 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 52 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2024
FIGURE 53 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025 TO 2032 (USD THOUSAND)
FIGURE 54 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2025- 2032)
FIGURE 55 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 56 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2024
FIGURE 57 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025 TO 2032 (USD THOUSAND)
FIGURE 58 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2025- 2032)
FIGURE 59 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE
FIGURE 60 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2024
FIGURE 61 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 62 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2025- 2032)
FIGURE 63 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 64 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2024
FIGURE 65 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 66 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2025- 2032)
FIGURE 67 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE
FIGURE 68 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 69 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 70 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2032)
FIGURE 71 BENELUX POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 72 BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)
FIGURE 73 GSA POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT (2024)
FIGURE 74 GSA AND BENELUX POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY SHARE 2024 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
